The study of innate immune-based algorithms is an important research domain in Artificial Immune System (AIS), such as Dendritic Cell Algorithm (DCA), Toll-Like Receptor algorithm (TLRA). The parameters in these algorithms usually require either manually pre-defined usually provided by the immunologists, or empirically derived from the training dataset, and result in poor self-adaptation and self-learning. The fundamental reason is that the original innate immune mechanisms lack adaptive biological theory. To solve this problem, a theory called ‘Trained Immunity™ or Innate Immune Memory (IIM)™ that thinks innate immunity can also build immunological memory to enhance the immune system™s learning and adaptive reactions to the second stimulus is introduced into AIS to improve the innate immune algorithms™ adaptability. In this study, we present an overview of IIM with particular emphasis on analogies in the AIS world, and a modified DCA with an effective automated tuning mechanism based on IIM (IIM-DCA) to optimize migration threshold of DCA. The migration threshold of Dendritic Cells (DCs) determines the lifespan of the antigen collected by DCs, and directly affect the detection speed and accuracy of DCA. Experiments on real datasets show that our proposed IIM-DCA which integrates Innate Immune Memory mechanism delivers more accurate results.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8852961PMC
http://dx.doi.org/10.1007/s11227-021-04295-1DOI Listing

Publication Analysis

Top Keywords

innate immune
20
immune memory
12
artificial immune
8
migration threshold
8
innate
7
immune
7
memory
4
memory application
4
application artificial
4
immune systems
4

Similar Publications

Introduction: Non-Celiac Gluten Sensitivity (NCGS) is a common disorder characterized by symptoms resembling those of irritable bowel syndrome. In recent years there has been progress in the understanding of the pathogenic pathways and data suggest that NCGS has a distinct immunological profile that differs from celiac disease (CeD). This has fostered the search for a specific biomarker of NCGS.

View Article and Find Full Text PDF

A safe haven for cancer cells: tumor plus stroma control by DYRK1B.

Oncogene

January 2025

Department of Gastroenterology, Endocrinology and Metabolism, Center for Tumor and Immune Biology, Philipps University Marburg, Marburg, Germany.

The development of resistance remains one of the biggest challenges in clinical cancer patient care and it comprises all treatment modalities from chemotherapy to targeted or immune therapy. In solid malignancies, drug resistance is the result of adaptive processes occurring in cancer cells or the surrounding tumor microenvironment (TME). Future therapy attempts will therefore benefit from targeting both, tumor and stroma compartments and drug targets which affect both sides will be highly appreciated.

View Article and Find Full Text PDF

There are few in vitro models available to study microglial physiology in a homeostatic context. Recent approaches include the human induced pluripotent stem cell model, but these can be challenging for large-scale assays and may lead to batch variability. To advance our understanding of microglial biology while enabling scalability for high-throughput assays, we developed an inducible immortalized murine microglial cell line using a tetracycline expression system.

View Article and Find Full Text PDF

Characterizing tumor-infiltrating group 1 innate lymphoid cells in PyMT breast tumors.

Methods Cell Biol

January 2025

Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada; Arnie Charbonneau Cancer Research Institute, Calgary, AB, Canada. Electronic address:

Breast cancer is the most common cancer in women and continues to have a significant impact in cancer-associated deaths worldwide. Investigating the complex roles of infiltrating immune subsets within the tumor microenvironment (TME) will enable a better understanding of disease progression and reveal novel therapeutic strategies for patients with breast cancer. The mammary-specific expression of polyomavirus middle T oncoprotein (MMTV-PyMT) was first established in 1992 by William Muller and is the most commonly used genetically engineered mouse model (GEMM) for breast cancer research.

View Article and Find Full Text PDF

Objective: Metabolic reprogramming plays a critical role in modulating the innate and adaptive immune response, but its role in cutaneous autoimmune diseases, such as cutaneous lupus erythematosus (CLE), is less well studied. An improved understanding of the metabolic pathways dysregulated in CLE may lead to novel treatment options, biomarkers and insights into disease pathogenesis. The objective was to compare metabolomic profiles in the skin and sera of CLE and control patients using liquid chromatography-mass spectrometry (LC-MS).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!